These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10656067

  • 1. Dornase alpha and survival of patients with cystic fibrosis.
    McIntyre AM.
    Hosp Med; 1999 Oct; 60(10):736-9. PubMed ID: 10656067
    [Abstract] [Full Text] [Related]

  • 2. The role of dornase alfa in the treatment of cystic fibrosis.
    Cramer GW, Bosso JA.
    Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM, Anderson L.
    Pharmacotherapy; 1996 Jun; 16(1):40-8. PubMed ID: 8700791
    [Abstract] [Full Text] [Related]

  • 6. A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period.
    Shah PL, Conway S, Scott SF, Rainisio M, Wildman M, Stableforth D, Hodson ME.
    Respiration; 2001 Jun; 68(2):160-4. PubMed ID: 11287830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
    Conway SP.
    Arch Dis Child; 1997 Jul; 77(1):1-3. PubMed ID: 9279142
    [No Abstract] [Full Text] [Related]

  • 11. Dornase alfa improves the health-related quality of life among Brazilian patients with cystic fibrosis--a one-year prospective study.
    Rozov T, de Oliveira VZ, Santana MA, Adde FV, Mendes RH, Paschoal IA, Caldeira Reis FJ, Higa LY, Toledo AC, Pahl M, Pulmozyme Study Group.
    Pediatr Pulmonol; 2010 Sep; 45(9):874-82. PubMed ID: 20583292
    [Abstract] [Full Text] [Related]

  • 12. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
    Christopher F, Chase D, Stein K, Milne R.
    J Clin Pharm Ther; 1999 Dec; 24(6):415-26. PubMed ID: 10651974
    [Abstract] [Full Text] [Related]

  • 13. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD, Nahata MC.
    J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
    [Abstract] [Full Text] [Related]

  • 14. Dornase alfa therapy in cystic fibrosis: who should get it?
    Kanga JF.
    Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Current therapeutic agents: dornase alfa].
    Baran D, Sternon J.
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.